Search Prime Grants

UM1TR004398

Cooperative Agreement

Overview

Grant Description
Tufts Clinical and Translational Science Institute - Tufts CTSI Overall Project Summary

Over its 14 years, Tufts Clinical and Translational Science Institute (CTSI) has brought together partners and collaborators and has grown programs and activities to catalyze clinical and translational research (CTR) and to advance innovation in clinical and translational science (CTS). We focus on what we are best suited to do, based on our skills, resources, partners, and opportunities. Thereby, we provide outstanding services, resources, education, and mentorship, and conduct innovative research contributing to the field of CTS, locally and nationally.

With this application, retaining our important structural features of integration across all of Tufts University, of having purposefully-selected partners, and adhering to our foundational principles, we are pleased to further grow our offerings and ambitions leveraging our long-standing partners' contributions and assets and by adding the special assets of new partners. With growth, our foundational principles have not changed. We actively support the full spectrum of translational research, we practice "broadly-engaged team science," and we are active collaborators, embracing our role as "the extrovert CTSA." We believe that only by having systems and processes to continually assess and improve methods and operational principles will we achieve CTR/CTS excellence. We practice inclusive communications and work to advance health equity. And we insist that wherever work is on the T.5-T4 continuum, CTR must have a clear line of sight to potential ultimate impact on health.

In addition to these foundational principles, in all we do, we reflexively look for opportunities to contribute novel research methods. Development, demonstration, and dissemination of new methods and approaches are hallmarks of our work, regardless of domain. Also, we manifest our belief that rigorous role-specific inclusive education and training are fundamental to excellence and advancing CTR/CTS.

In service of these principles, our aims are:

Overall Aim 1: Harness the collective impact of Tufts CTSI to advance CTS and improve public health through responsive hub leadership, an inclusive and collaborative culture, and continuous improvement of programs and research.

Overall Aim 2: Provide outstanding education, training, and mentoring, tailored to different roles and disciplines, to develop an expert and diverse CTS workforce, and share these resources nationally.

Overall Aim 3: Cultivate broadly-engaged team science, with active inclusion of all stakeholders, to promote relevant and impactful translation for diverse populations and to promote health equity.

Overall Aim 4: Create the environment, resources, and services to stimulate and support the full spectrum of CTS by leveraging the diverse expertise and assets of Tufts CTSI partners.

Overall Aim 5: Foster translation by developing, demonstrating, and disseminating innovations that address significant translational roadblocks and provide generalizable translational insights and solutions.
Funding Goals
NOT APPLICABLE
Place of Performance
Massachusetts United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the total obligations have increased 3% from $22,788,488 to $23,585,245.
Trustees Of Tufts College was awarded Tufts CTSI: Advancing Clinical & Translational Science Cooperative Agreement UM1TR004398 worth $23,585,245 from National Center for Advancing Translational Sciences in May 2023 with work to be completed primarily in Massachusetts United States. The grant has a duration of 7 years and was awarded through assistance program 93.350 National Center for Advancing Translational Sciences. The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 5/20/24

Period of Performance
5/1/23
Start Date
4/30/30
End Date
17.0% Complete

Funding Split
$23.6M
Federal Obligation
$0.0
Non-Federal Obligation
$23.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UM1TR004398

Subgrant Awards

Disclosed subgrants for UM1TR004398

Transaction History

Modifications to UM1TR004398

Additional Detail

Award ID FAIN
UM1TR004398
SAI Number
UM1TR004398-3072864415
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Funding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Awardee UEI
C1F5LNUF7W86
Awardee CAGE
3G627
Performance District
MA-90
Senators
Edward Markey
Elizabeth Warren

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) Health research and training Grants, subsidies, and contributions (41.0) $12,369,297 100%
Modified: 5/20/24